Trials / Conditions / Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia
Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia
5 registered clinical trials studyying Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acu NCT01925131 | SWOG Cancer Research Network | Phase 1 |
| Withdrawn | Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Posit NCT01670084 | Mayo Clinic | Phase 2 |
| Completed | CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant NCT01475058 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Terminated | Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Posi NCT01383447 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00061945 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |